Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.

Education

Biotechnology

Shoreline Biosciences

Kleanthis G. Xanthopoulos

Krishna Patel

Mauro P. Avanzi

Paschalis Sideras

Charles Calderaro III

Robert Hollingsworth

Scott Forrest

Steven Neben

Vanessa Jacoby

Scientific Research

Leadership Team

Advisory Team

Finance and Accounting

Research and Development

Shoreline Biosciences

Org chart

Teams

Scientific Research

Leadership Team

Advisory Team

Finance and Accounting

Research and Development

Similar companies